Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
 
Register | Sign in
Home Page > Videos > Next Generation Sequencing Chips: Market & Technology Trends
  Videos

Return

Next Generation Sequencing Chips: Market & Technology Trends
Yole Developpement

In April 2003, the Human Genome Project was declared complete. This first human genome sequencing took 13 years, mobilized 20000 researchers and cost $3B! Since the early 2000s, sequencing technologies have come a long way from Sanger sequencing (also called 1st generation sequencing) used for the Human Genome Project to the Next Generation Sequencing technologies available today. Next Generation Sequencing (NGS) technologies have demonstrated the capacity to sequence DNA at unprecedented speed, enabling previously unimaginable novel healthcare applications. Indeed, by sequencing a large number of DNA molecules in parallel after PCR amplification, technology developers have been able to sharply increase machine throughput by a factor of 10. The launch of a new detection method based on electrochemical detections was also a huge step forward for the sequencing world. At the same time, price has taken a steep decline. Starting its transition from research to clinical market, the number of NGS Platforms used worldwide will surge in the next several years and the run time will continue to decrease. This will make the NGS Consumables market explode. Yole Développement foresees the NGS Consumables market growing to $3.1B in 2018, the result of several millions of cartridges being sold each year. This presentation will describe both market and technology trends of the NGS market.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
UTSW Cancer Researchers Identify Irreversible Inhibitor for KRAS Gene Mutation
Irreversible inhibitor for KRAS gene mutation involved in lung, colon, and pancreatic cancers.
NIH Scientists Find Six New Genetic Risk Factors for Parkinson’s
Study shows power of combining big data analysis with cutting-edge genomic techniques.
UT Southwestern Researchers Uncover New Brain Pathways
New therapies for treating Type 2 diabetes and obesity.
Mount Sinai Scientists and International Team Shed New Light on Schizophrenia
Genes and pathways identified could inform new approaches to treatment and address acute need for drug development for this disorder.
Mass Spec-Based Metabolomics Workflows to Evaluate Plant Immunity
This article reviews metabolomics studies used to evaluate plant immunity with an emphasis on mass spectrometry in its many forms.
Schizophrenia’s Genetic Skyline Rising
Suspect common variants soar from 30 to 108 - NIH-funded study.
UK Government Must Do More to Reduce Risk of vCJD Infection
Report recommends that UK Government commission a full assessment of the risks currently faced by the UK blood supply.
Future Directions of Forensic DNA Databases
With the great success of the use of forensic DNA databases, new challenges are emerging.
Current Developments in Forensic Interpretation of Mixed DNA Samples
It is of great significance to develop innovative experimental techniques and software appropriate for complex mixed DNA analysis.
Preparation of Phosphines Through C–P Bond Formation
This article reviews some of the most important C–P bond formation strategies, organizing them according to the hybridization of carbon in the newly formed C–P bond.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv